000 02924nam a22004695i 4500
001 u372604
003 SIRSI
005 20160812084106.0
007 cr nn 008mamaa
008 100528s2010 xxu| s |||| 0|eng d
020 _a9781607615545
_9978-1-60761-554-5
040 _cMX-MeUAM
050 4 _aRC254-282
082 0 4 _a616.994
_223
100 1 _aRoodman, G. David.
_eeditor.
245 1 0 _aMyeloma Bone Disease
_h[recurso electrónico] /
_cedited by G. David Roodman.
264 1 _aTotowa, NJ :
_bHumana Press,
_c2010.
300 _aX, 252p. 75 illus., 43 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aCurrent Clinical Oncology
505 0 _aClinical Presentation of Myeloma Bone Disease -- Imaging of Multiple Myeloma, Solitary Plasmacytoma, MGUS, and Other Plasma Cell Dyscrasias -- Biochemical Markers of Bone Remodeling in Multiple Myeloma -- Radiation Therapy in Multiple Myeloma -- Surgical Management of Bone Disease -- Bisphosphonates in the Treatment of Myeloma Bone Disease -- Osteonecrosis of the Jaw -- Murine Models of Myeloma Bone Disease: The Importance of Choice -- RANK Ligand Is a Therapeutic Target in Multiple Myeloma -- Osteoclast Activation in Multiple Myeloma -- Potential Role of IMiDs and Other Agents as Therapy for Myeloma Bone Disease -- Proteasome Inhibitors and the Wnt Signaling Pathway in Myeloma Bone Disease -- Mechanisms Involved in Osteoblast Suppression in Multiple Myeloma.
520 _aThis state-of-the-art book presents the forefront in the science and clinical management of myeloma bone disease. Assembling the work of the world's premier thought leaders, this book begins with sections on clinical presentation, imaging, and biochemical markers and then goes on to discuss radiation, surgical, and medical therapies. Specific chapters are devoted to bisphosphonates and novel therapeutic agents, such as RANKL inhibitors, Wnt signaling inhibitors, and IMiDs. The mechanisms of osteoclast activation and osteoblast suppression in multiple myeloma are also explored. Myeloma Bone Disease is a valuable resource for medical, surgical, and radiation oncologists and cancer researchers.
650 0 _aMedicine.
650 0 _aRadiotherapy.
650 0 _aHematology.
650 0 _aOncology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aOncology.
650 2 4 _aHematology.
650 2 4 _aRadiotherapy.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781607615538
830 0 _aCurrent Clinical Oncology
856 4 0 _zLibro electrónico
_uhttp://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-1-60761-554-5
596 _a19
942 _cLIBRO_ELEC
999 _c200484
_d200484